CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
CRISPR/Cas9 systems are a versatile tool for genome editing due to the highly efficient targeting of DNA sequences complementary to their RNA guide strands. However, it has been shown that RNA-guided Cas9 nuclease cleaves genomic DNA sequences containing mismatches to the guide strand. A better understanding of the CRISPR/Cas9 specificity is needed to minimize off-target cleavage in large mammalian genomes. Here we show that genomic sites could be cleaved by CRISPR/Cas9 systems when DNA sequences contain insertions ('DNA bulge') or deletions ('RNA bulge') compared to the RNA guide strand, and Cas9 nickases used for paired nicking can also tolerate bulges in one of the guide strands. Variants of single-guide RNAs (sgRNAs) for four endogenous loci were used as model systems, and their cleavage activities were quantified at different positions with 1- to 5-bp bulges. We further investigated 114 putative genomic off-target loci of 27 different sgRNAs and confirmed 15 off-target sites, each harboring a single-base bulge and one to three mismatches to the guide strand. Our results strongly indicate the need to perform comprehensive off-target analysis related to DNA and sgRNA bulges in addition to base mismatches, and suggest specific guidelines for reducing potential off-target cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Off-target genome editing is often hard to detect as it may vary among different cell types and species, along with different frequency influenced by the abundance of Cas9 proteins in the reaction, structure of sgRNA, and cellular state [125].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 2×
“The lack of activity with PAM-proximal sgRNA bulges in R01 and low levels of activity with PAM-proximal sgRNA bulges in R-30 are consistent with the reduced mismatch tolerance in the ‘seed sequence’ reported in previous studies (9,11,33).”
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · cited 2×
“For example, the sgRNA–DNA interfaces corresponding to removing 5′-end bases in the guide sequences (positions 18 and 19 of the R-01 interface and 16–19 of the R-30 interface) can be viewed as having DNA bulges or having mismatches in the 5′-end region of sgRNA, which have been shown to be better tolerated compared to…”
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 1×
“Chimeric single-guided RNAs (sgRNAs) based on CRISPR (9) have been engineered to direct the Cas9 nuclease to cleave complementary genomic sequences when followed by a 5 -NGG protospacer-adjacent motif (PAM) in eukaryotic cells (10–12).”
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 1×
“However, these positions seem to group in the 5 -end, middle and 3 -end regions of the target loci, as in both R-01 and R-30 sgRNA–DNA interfaces, single-base DNA-bulges at the following five positions seems to be tolerated: positions 1, 2, 7, 18 and 19.”
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741 · cited 6×
“For example, the sgRNA–DNA interfaces corresponding to removing 5′-end bases in the guide sequences (positions 18 and 19 of the R-01 interface and 16–19 of the R-30 interface) can be viewed as having DNA bulges or having mismatches in the 5′-end region of sgRNA, which have been shown to be better tolerated compared to…”
InfluentialDouble nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 2×
“Consistent with previous studies showing that the specificity of CRISPR/Cas9 systems is guide-strand and target-site dependent (19,20,22), the positions in R-01 sgRNA variants where DNA-bulges were tolerated are different from that in R-30 sgRNA variants.”
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Cited by
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
“Asymmetric sgRNA:DNA interactions that lead to bulged RNA or DNA bases have been examined for a small number of examples and our results are qualitatively consistent 41 .”
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,801
CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites
Naito, Y., Hino, K., Bono, H., & Ui-Tei, K. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu743 · Cited by 1,281
“Conflict of interest: none declared.”
High-throughput functional genomics using CRISPR-Cas9
Shalem, O., Sanjana, N. E., & Zhang, F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3899 · Cited by 1,233
The CRISPR/Cas9 system for plant genome editing and beyond
Bortesi, L., & Fischer, R. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.006 · Cited by 1,187
“DNA sequences that contain an extra base (DNA bulge) or a missing base (gRNA bulge) at various locations along the corresponding gRNA sequence have also been shown to induce off-target cleavage (Lin et al., 2014).”
BackgroundEnhanced proofreading governs CRISPR-Cas9 targeting accuracy
Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168
Digenome-seq: Genome-wide profiling of CRISPR-cas9 off-target effects in human cells
Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., Hwang, J., Kim, J.-I., & Kim, J.-S. (2015) · Nature Methods · doi:10.1038/nmeth.3284 · Cited by 992
Wang, F., Wang, C., Liu, P., Lei, C., Hao, W., Gao, Y., Liu, Y.-G., & Zhao, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154027 · Cited by 819
“For example, previous studies have demonstrated that off-target effects were common at the level of one nucleotide mismatch in plant species [37, 50], fish [79] and human cells [80, 81].”
ResultBroadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Topkar, V. V., Zheng, Z., & Joung, J. K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3404 · Cited by 611
Past, present, and future of CRISPR genome editing technologies
Pacesa, M., Pelea, O., & Jinek, M. (2024) · Cell · doi:10.1016/j.cell.2024.01.042 · Cited by 609
The CRISPR-Cas immune system: Biology, mechanisms and applications
Rath, D., Amlinger, L., Rath, A., & Lundgren, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.025 · Cited by 471
“unintended target, are a concern [109] but strategies for prediction”
BackgroundWang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Self-citationLawrenson, T., Shorinola, O., Stacey, N., Li, C., Østergaard, L., Patron, N., Uauy, C., & Harwood, W. (2015) · Genome Biology · doi:10.1186/s13059-015-0826-7 · Cited by 551
Li, H. L., Fujimoto, N., Sasakawa, N., Shirai, S., Ohkame, T., Sakuma, T., Tanaka, M., Amano, N., Watanabe, A., Sakurai, H., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.013 · Cited by 471
“Before the TALEN and CRISPR systems can reach clinical application, however, target specificity must be improved, as high off-target mutagenesis rates in human cells have been reported (Fu et al., 2013; Hsu et al., 2013; Lin et al., 2014), although some reports have shown otherwise (Smith et al.”
BackgroundDefining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
Tsai, S. Q., & Joung, J. K. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.28 · Cited by 510
Cas-Designer: a web-based tool for choice of CRISPR-Cas9 target sites
Park, J., Bae, S., & Kim, J.-S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv537 · Cited by 488
“However, RGENs can also cleave off-target DNA sites with several mismatches (Cho et al., 2014; Fu et al., 2013) or with missing or additional nucleotides (Lin et al., 2014), compared to gRNA sequences.”
BackgroundEfficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9
Mandal, P. K., Ferreira, L. M. R., Collins, R., Meissner, T. B., Boutwell, C. L., Friesen, M., Vrbanac, V., Garrison, B. S., Stortchevoi, A., Bryder, D., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.004 · Cited by 475
“CRISPR/Cas9 has been shown to generate off-target mutations depending upon experimental setting and cell type (Cho et al., 2014; Cradick et al., 2013; Fu et al., 2013; Fu et al., 2014; Hruscha et al., 2013; Lin et al., 2014).”
Mans, R., van Rossum, H. M., Wijsman, M., Backx, A., Kuijpers, N. G. A., van den Broek, M., Daran-Lapujade, P., Pronk, J. T., van Maris, A. J. A., & Daran, J.-M. G. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov004 · Cited by 485
“Therefore, it is logical to speculate that this methodology should have an even higher impact on species of yeasts and filamentous fungi that are notoriously more difficult to alter genetically.”
BackgroundOusterout, D. G., Kabadi, A. M., Thakore, P. I., Majoros, W. H., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Communications · doi:10.1038/ncomms7244 · Cited by 470
“Notably, these sequencing results also showed a strong preference for single base-pair insertions, consistent with previous studies 41 , as well as enrichment for specific indels that are likely mediated by microhomology at the DNA break 42 and could be used to favor conversion to specific reading…”
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Gomes-Silva, D., Srinivasan, M., Sharma, S., Lee, C. M., Wagner, D. L., Davis, T. H., Rouce, R. H., Bao, G., Brenner, M. K., & Mamonkin, M. (2017) · Blood · doi:10.1182/blood-2017-01-761320 · Cited by 462
Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Naeem, M., Majeed, S., Hoque, M. Z., & Ahmad, I. (2020) · Cells · doi:10.3390/cells9071608 · Cited by 457
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3127 · Cited by 442
Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae
Jakočiūnas, T., Bonde, I., Herrgård, M., Harrison, S. J., Kristensen, M., Pedersen, L. E., Jensen, M. K., & Keasling, J. D. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.01.008 · Cited by 415
COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J., & Bao, G. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.64 · Cited by 408
Self-citationManghwar, H., Li, B., Ding, X., Hussain, A., Lindsey, K., Zhang, X., & Jin, S. (2020) · Advanced Science · doi:10.1002/advs.201902312 · Cited by 347
Pan, C., Ye, L., Qin, L., Liu, X., He, Y., Wang, J., Chen, L., & Lu, G. (2016) · Scientific Reports · doi:10.1038/srep24765 · Cited by 375
Target specificity of the CRISPR‐Cas9 system
Wu, X., Kriz, A. J., & Sharp, P. A. (2014) · Quantitative Biology · doi:10.1007/s40484-014-0030-x · Cited by 363
“that contain insertions or deletions relative to the guide RNA; however many of these sites could be alternatively aligned to contain only mismatches to the guide [61].”
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
Morgens, D. W., Wainberg, M., Boyle, E. A., Ursu, O., Araya, C. L., Tsui, C. K., Haney, M. S., Hess, G. T., Han, K., Jeng, E. E., et al. (2017) · Nature Communications · doi:10.1038/ncomms15178 · Cited by 360
CRISPR/Cas9-mediated targeted mutagenesis in Nicotiana tabacum
Gao, J., Wang, G., Ma, S., Xie, X., Wu, X., Zhang, X., Wu, Y., Zhao, P., & Xia, Q. (2015) · Plant Molecular Biology · doi:10.1007/s11103-014-0263-0 · Cited by 343
“It has been reported that the offtarget effect of CRISPR/Cas-induced mutagenesis occurred in human cells, medaka, zebrafish and rice (Ansai and Kinoshita 2014; Fu et al. 2013; Hruscha et al. 2013; Lin et al. 2014; Xie and Yang 2013).”
BackgroundZischewski, J., Fischer, R., & Bortesi, L. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.003 · Cited by 323
Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs
Listgarten, J., Weinstein, M., Kleinstiver, B. P., Sousa, A. A., Joung, J. K., Crawford, J., Gao, K., Hoang, L., Elibol, M., Doench, J. G., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0178-6 · Cited by 336
Ren, X., Yang, Z., Xu, J., Sun, J., Mao, D., Hu, Y., Yang, S.-J., Qiao, H.-H., Wang, X., Hu, Q., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.044 · Cited by 309
“Furthermore, we evaluated the mutation rates at potential off-target sites with two mismatches and one insertion/deletion to 13 sgRNAs (Lin et al., 2014), and again observed no off-target effects (Figure S1B).”
BackgroundTang, X., Liu, G., Zhou, J., Ren, Q., You, Q., Tian, L., Xin, X., Zhong, Z., Liu, B., Zheng, X., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1458-5 · Cited by 306
“Cas9 was previously shown to induce off-target mutations at sites with missing or extra nucleotides when compared to the target site, which forms bulges when targeted by guide RNAs [35].”
BackgroundCRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Ramanan, V., Shlomai, A., Cox, D. B. T., Schwartz, R. E., Michailidis, E., Bhatta, A., Scott, D. A., Zhang, F., Rice, C. M., & Bhatia, S. N. (2015) · Scientific Reports · doi:10.1038/srep10833 · Cited by 304
Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
Zuccaro, M. V., Xu, J., Mitchell, C., Marin, D., Zimmerman, R., Rana, B., Weinstein, E., King, R. T., Palmerola, K. L., Smith, M. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.025 · Cited by 303
One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces
Huang, H., Zheng, G., Jiang, W., Hu, H., & Lu, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv007 · Cited by 289
“The high efficiency and convenience of CRISPR/Cas9 technology favor its application in eukaryotic cells, and the off-target effects have drawn the attention of investigators in these systems [55–58].”
BackgroundGenome-wide target specificities of CRISPR RNA-guided programmable deaminases
Kim, D., Lim, K., Kim, S.-T., Yoon, S.-H., Kim, K., Ryu, S.-M., & Kim, J.-S. (2017) · Nature Biotechnology · doi:10.1038/nbt.3852 · Cited by 276
Predicting the efficiency of prime editing guide RNAs in human cells
Kim, H. K., Yu, G., Park, J., Min, S., Lee, S., Yoon, S., & Kim, H. H. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0677-y · Cited by 276
Optical Control of CRISPR/Cas9 Gene Editing
Hemphill, J., Borchardt, E. K., Brown, K., Asokan, A., & Deiters, A. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512664v · Cited by 269
Genome modification by CRISPR/Cas9
Ma, Y., Zhang, L., & Huang, X. (2014) · The FEBS Journal · doi:10.1111/febs.13110 · Cited by 266
Streptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
Potential pitfalls of CRISPR/Cas9‐mediated genome editing
Peng, R., Lin, G., & Li, J. (2016) · The FEBS Journal · doi:10.1111/febs.13586 · Cited by 213
The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
Lee, C. M., Cradick, T. J., & Bao, G. (2016) · Molecular Therapy · doi:10.1038/mt.2016.8 · Cited by 246
“Previous studies have shown that Spy CRISPR-Cas9 systems can tolerate genomic target sites containing base mismatches, single-base DNA insertions (DNA bulges) and single-base DNA deletions (RNA bulges), 13–16 which have significant implications to the targeting specificity of CRISPR-Cas9.”
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
Ho, T.-T., Zhou, N., Huang, J., Koirala, P., Xu, M., Fung, R., Wu, F., & Mo, Y.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1198 · Cited by 244
“Therefore, our dual gRNA approach increases the targeting efficiency by CRISPR/Cas9 system, demonstrating its feasibility for targeting lncRNAs with ei- ther a short fragment (475 bp for lncRNA-21A) or a relatively long fragment (>5.6 kb for UCA1).”
BackgroundInfluentialReview of CRISPR/Cas9 sgRNA Design Tools
Cui, Y., Xu, J., Cheng, M., Liao, X., & Peng, S. (2018) · Interdisciplinary Sciences: Computational Life Sciences · doi:10.1007/s12539-018-0298-z · Cited by 245
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
Li, A., Tanner, M. R., Lee, C. M., Hurley, A. E., De Giorgi, M., Jarrett, K. E., Davis, T. H., Doerfler, A. M., Bao, G., Beeton, C., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.017 · Cited by 230
Self-citationHarrison, M. M., Jenkins, B. V., O’Connor-Giles, K. M., & Wildonger, J. (2014) · Genes & Development · doi:10.1101/gad.248252.114 · Cited by 226
“GENES & DEVELOPMENT 1861 2013; Mali et al. 2013a; Ran et al. 2013; Chen et al. 2014; Cho et al. 2014; Fauser et al. 2014; Fujii et al. 2014; Lin et al. 2014; Rong et al. 2014; Shen et al. 2014).”
Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase
Xu, T., Li, Y., Shi, Z., Hemme, C. L., Li, Y., Zhu, Y., Van Nostrand, J. D., He, Z., & Zhou, J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00873-15 · Cited by 223
“Loss of specificity in the seed region will dramatically decrease editing precision such that off-target mutations would occur (43, 44).”
BackgroundCRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Hoban, M. D., Lumaquin, D., Kuo, C. Y., Romero, Z., Long, J., Ho, M., Young, C. S., Mojadidi, M., Fitz-Gibbon, S., Cooper, A. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.148 · Cited by 220
CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
Tang, L., Zeng, Y., Du, H., Gong, M., Peng, J., Zhang, B., Lei, M., Zhao, F., Wang, W., Li, X., et al. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1299-z · Cited by 220
“These data indicated that the CRISPR/Cas9 system may also tolerate a one base indel at the sgRNA targeting site in human zygotes using Cas9 protein (Lin et al. 2014b).”
Li, C., Guan, X., Du, T., Jin, W., Wu, B., Liu, Y., Wang, P., Hu, B., Griffin, G. E., Shattock, R. J., et al. (2015) · Journal of General Virology · doi:10.1099/vir.0.000139 · Cited by 192
CRISPR off-target analysis in genetically engineered rats and mice
Anderson, K. R., Haeussler, M., Watanabe, C., Janakiraman, V., Lund, J., Modrusan, Z., Stinson, J., Bei, Q., Buechler, A., Yu, C., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0011-5 · Cited by 216
Pasitka, L., Cohen, M., Ehrlich, A., Gildor, B., Reuveni, E., Ayyash, M., Wissotsky, G., Herscovici, A., Kaminker, R., Niv, A., et al. (2022) · Nature Food · doi:10.1038/s43016-022-00658-w · Cited by 208
Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq
Kim, D., Kim, S., Kim, S., Park, J., & Kim, J.-S. (2016) · Genome Research · doi:10.1101/gr.199588.115 · Cited by 208
“We also found that sgRNAs transcribed using a plasmid template in a Digenome-seq analysis did not cleave any of the false-positive, bulge-type off-target sites, with a missing nucleotide (nt) compared to the on-target site(Lin et al. 2014), which were captured with those transcribed using an oligonucleotide duplex (Fi…”
MethodMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
Koo, T., Lee, J., & Kim, J.-S. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0103 · Cited by 207
“Furthermore, RGENs can cleave off-target sites with a few extra or missing nucleotides that can produce a DNA or RNA bulge, respectively (Lin et al., 2014).”
BackgroundEngineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 205
Abadi, S., Yan, W. X., Amar, D., & Mayrose, I. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005807 · Cited by 197
Structural basis for Cas9 off-target activity
Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.026 · Cited by 198
Obesity genetics in mouse and human: back and forth, and back again
Yazdi, F. T., Clee, S. M., & Meyre, D. (2015) · PeerJ · doi:10.7717/peerj.856 · Cited by 196
Lee, J. S., Kallehauge, T. B., Pedersen, L. E., & Kildegaard, H. F. (2015) · Scientific Reports · doi:10.1038/srep08572 · Cited by 195
Lentivirus pre-packed with Cas9 protein for safer gene editing
Choi, J. G., Dang, Y., Abraham, S., Ma, H., Zhang, J., Guo, H., Cai, Y., Mikkelsen, J. G., Wu, H., Shankar, P., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.27 · Cited by 192
Magnetic iron oxide nanoparticles for disease detection and therapy
Tong, S., Zhu, H., & Bao, G. (2019) · Materials Today · doi:10.1016/j.mattod.2019.06.003 · Cited by 190
Genome Editing in Plants: Exploration of Technological Advancements and Challenges
Vats, S., Kumawat, S., Kumar, V., Patil, G. B., Joshi, T., Sonah, H., Sharma, T. R., & Deshmukh, R. (2019) · Cells · doi:10.3390/cells8111386 · Cited by 190
“Other strategies include: selecting target sites with a higher GC content (up to 70%) [156]; truncating sgRNAs at 3′ [157,158] or 5′-end [159] and adding extra GG at the 5′ end; using paired sgRNA Cas9 nickases; utilizing the FokI nuclease to guide Cas9 [115,160].”
MethodGene correction for SCID-X1 in long-term hematopoietic stem cells
Pavel-Dinu, M., Wiebking, V., Dejene, B. T., Srifa, W., Mantri, S., Nicolas, C. E., Lee, C., Bao, G., Kildebeck, E. J., Punjya, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09614-y · Cited by 167
Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
Ceasar, S. A., Rajan, V., Prykhozhij, S. V., Berman, J. N., & Ignacimuthu, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.06.009 · Cited by 151
Fu, Y.-W., Dai, X.-Y., Wang, W.-T., Yang, Z.-X., Zhao, J.-J., Zhang, J.-P., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 180
“The constitutive expression of Cas9–gRNA might lead to a considerable decrease in NHEJ because the same gRNA may still identify a single nucleotide insertion or deletion of the target (59).”
BackgroundCRISPR-Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing
Chiang, T.-W. W., le Sage, C., Larrieu, D., Demir, M., & Jackson, S. P. (2016) · Scientific Reports · doi:10.1038/srep24356 · Cited by 172
Savic, N., Ringnalda, F. C., Lindsay, H., Berk, C., Bargsten, K., Li, Y., Neri, D., Robinson, M. D., Ciaudo, C., Hall, J., et al. (2018) · eLife · doi:10.7554/elife.33761 · Cited by 173
“In addition, the analysis of three computationally predicted off-target sites (Lin et al., 2014b; Cradick et al., 2014) of the reporter locus, suggests that the risk for generating off-target mutations is not enhanced with the RNPD system (Figure 6c, Supplementary file 2,3,4).”
BackgroundJakočiu̅nas, T., Rajkumar, A. S., Zhang, J., Arsovska, D., Rodriguez, A., Jendresen, C. B., Skjødt, M. L., Nielsen, A. T., Borodina, I., Jensen, M. K., et al. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00007 · Cited by 166
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
Barrangou, R., Birmingham, A., Wiemann, S., Beijersbergen, R. L., Hornung, V., & Smith, A. V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv226 · Cited by 165
Patterns of CRISPR/Cas9 activity in plants, animals and microbes
Bortesi, L., Zhu, C., Zischewski, J., Perez, L., Bassié, L., Nadi, R., Forni, G., Lade, S. B., Soto, E., Jin, X., et al. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12634 · Cited by 161
“However, indels in the alignment between the target and the sgRNA are not taken into account by most online tools (Lin et al., 2014).”
BackgroundChen, F., Ding, X., Feng, Y., Seebeck, T., Jiang, Y., & Davis, G. D. (2017) · Nature Communications · doi:10.1038/ncomms14958 · Cited by 157
CRISPR interference-based specific and efficient gene inactivation in the brain
Zheng, Y., Shen, W., Zhang, J., Yang, B., Liu, Y., Qi, H., Yu, X., Lu, S., Chen, Y., Xu, Y., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0077-5 · Cited by 175
Systematic analysis of CRISPR–Cas9 mismatch tolerance reveals low levels of off-target activity
Anderson, E. M., Haupt, A., Schiel, J. A., Chou, E., Machado, H. B., Strezoska, Ž., Lenger, S., McClelland, S., Birmingham, A., Vermeulen, A., et al. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.06.427 · Cited by 157
Spatial control of in vivo CRISPR–Cas9 genome editing via nanomagnets
Zhu, H., Zhang, L., Tong, S., Lee, C. M., Deshmukh, H., & Bao, G. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0318-7 · Cited by 151
Park, S. H., Lee, C. M., Dever, D. P., Davis, T. H., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A. K., Porteus, M. H., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz475 · Cited by 148
“Although CRISPR/Cas9 systems can have highly efficient gene editing at the intended target site, off-target cutting may occur due to the tolerance for base mismatches, small insertions and deletions between DNA sequences in the genome and the intended 20-nt gRNA target sequence (23,25,52,53).”
BackgroundKang, H., Minder, P., Park, M. A., Mesquitta, W.-T., Torbett, B. E., & Slukvin, I. I. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.42 · Cited by 158
Kim, H. K., Lee, S., Kim, Y., Park, J., Min, S., Choi, J. W., Huang, T. P., Yoon, S., Liu, D. R., & Kim, H. H. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0505-1 · Cited by 145
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Liu, Z., Shi, M., Ren, Y., Xu, H., Weng, S., Ning, W., Ge, X., Liu, L., Guo, C., Duo, M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01738-6 · Cited by 176
Li, J., Shou, J., Guo, Y., Tang, Y., Wu, Y., Jia, Z., Zhai, Y., Chen, Z., Xu, Q., & Wu, Q. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv016 · Cited by 138
“Potential off-target sites of sgRNAs were predicted by searching the human genome sequences (Supplementary Table S3) (Mali et al., 2013c; Wang et al., 2013; Lin et al., 2014).”
BackgroundEngineering CRISPR–Cpf1 crRNAs and mRNAs to maximize genome editing efficiency
Li, B., Zhao, W., Luo, X., Zhang, X., Li, C., Zeng, C., & Dong, Y. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0066 · Cited by 136
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 134
Vaidyanathan, S., Salahudeen, A. A., Sellers, Z. M., Bravo, D. T., Choi, S. S., Batish, A., Le, W., Baik, R., de la O, S., Kaushik, M. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.11.002 · Cited by 133
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
Jones, S. K., Hawkins, J. A., Johnson, N. V., Jung, C., Hu, K., Rybarski, J. R., Chen, J. S., Doudna, J. A., Press, W. H., & Finkelstein, I. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0646-5 · Cited by 137
Implications of human genetic variation in CRISPR-based therapeutic genome editing
Scott, D. A., & Zhang, F. (2017) · Nature Medicine · doi:10.1038/nm.4377 · Cited by 129
A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
Li, A., Lee, C. M., Hurley, A. E., Jarrett, K. E., De Giorgi, M., Lu, W., Balderrama, K. S., Doerfler, A. M., Deshmukh, H., Ray, A., et al. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.11.009 · Cited by 128
“Genomic DNA extracted from mouse livers was amplified using locus-specific primers containing common adaptor sequences, and a second round of PCR amplification was used to add sample indexes as previously described.(45) Amplicons for all target regions were purified using magnetic beads, pooled in equimolar amounts, a…”
MethodThe potential for the use of gene drives for pest control in New Zealand: a perspective
Dearden, P. K., Gemmell, N. J., Mercier, O., Lester, P. J., Scott, M. J., Newcomb, R. D., Buckley, T. R., Jacobs, J. M. E., Goldson, S. L., & Penman, D. R. (2017) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2017.1385030 · Cited by 137
“It should also be noted that CRISPR/Cas9 targeting events also cause off-target effects, causing sequence change distant from the targeted site (Lin et al. 2014; Shin et al. 2017).”
BackgroundFrom Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
Hotta, A., & Yamanaka, S. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054926 · Cited by 123
Lee, C. M., Cradick, T. J., Fine, E. J., & Bao, G. (2016) · Molecular Therapy · doi:10.1038/mt.2016.1 · Cited by 121
Simple and Efficient Targeting of Multiple Genes Through CRISPR-Cas9 in Physcomitrella patens
Lopez-Obando, M., Hoffmann, B., Géry, C., Guyon-Debast, A., Téoulé, E., Rameau, C., Bonhomme, S., & Nogué, F. (2016) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.033266 · Cited by 117
“However, it will be important to conduct a comprehensive genome analysis of mutant individuals, as noncanonical off-targets caused by DNA bulges (insertions) have been reported in human cells (Lin et al. 2014).”
CRISPR/Cas9-mediated genome engineering of CHO cell factories: application and perspectives
Lee, J. S., Grav, L. M., Lewis, N. E., & Faustrup Kildegaard, H. (2015) · Biotechnology Journal · doi:10.1002/biot.201500082 · Cited by 117
“However, contrasting results from this approach have been reported [44, 49, 87].”
ResultCRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
Karimova, M., Beschorner, N., Dammermann, W., Chemnitz, J., Indenbirken, D., Bockmann, J., Grundhoff, A. T., Lüth, S., Buchholz, F., Wiesch, J. S. Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13734 · Cited by 130
DNA-binding-domain fusions enhance the targeting range and precision of Cas9
Bolukbasi, M. F., Gupta, A., Oikemus, S., Derr, A. G., Garber, M., Brodsky, M. H., Zhu, L. J., & Wolfe, S. A. (2015) · Nature Methods · doi:10.1038/nmeth.3624 · Cited by 115
Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules
Klein, M., Eslami-Mossallam, B., Arroyo, D. G., & Depken, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.045 · Cited by 115
“…biochemical studies (Anderson et al., 2015; Cong et al., 2013; Doench et al., 2016; Jinek et al., 2012; Kim et al., 2016; Kleinstiver et al., 2016a; Lin et al., 2014; Ran et al., 2015; Semenova et al., 2011); structural studies (Anders et al., 2014; Jiang et al., 2015, 2016; Jinek et al., 2014;…”
BackgroundHow specific is CRISPR/Cas9 really?
O’Geen, H., Yu, A. S., & Segal, D. J. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.10.001 · Cited by 111
“In addition to mismatches, some sgRNAs can also tolerate DNA sequences with an extra base (DNA bulge) or a missing base (sgRNA bulge) [13] (Figure 3).”
Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery
Bolukbasi, M. F., Gupta, A., & Wolfe, S. A. (2015) · Nature Methods · doi:10.1038/nmeth.3684 · Cited by 118
Metadata
- Authors
- Lin, Y., Cradick, T. J., Brown, M. T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B. M., Vertino, P. M., Stewart, F. J., & Bao, G.
- Affiliations
- Georgia Institute of Technology (US)
- Emory University (US)
- Corresponding author
- Bao, G.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-16
- Volume
- 42
- Issue
- 11
- Pages
- 7473-7485
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4066799
- OpenAlex
- W2128758977
- Cited by
- 634
- References
- 37
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 34 · 2023: 49 · 2022: 60 · 2021: 58 · 2020: 66 · 2019: 55 · 2018: 46 · 2017: 54 · 2016: 65 · 2015: 60 · 2014: 22
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Emory University
- National Institutes of Health (4r01ca077337-15)
- National Eye Institute (PN2EY018244)
- National Cancer Institute (R01-CA077337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, off-target cleavage, bulge, single guide RNA, DNA bulges, RNA bulge, mismatched base pairs, Cas9 nickase, genome editing specificity
- MeSH terms
- Base Composition, Base Sequence, Cytosine, Deoxyribonucleases, DNA, Guanine, Humans, Sequence Deletion, Base Pair Mismatch, DNA Cleavage, HEK293 Cells, RNA, Small Untranslated, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.